TAYSHA GENE THERAPIES INC (TSHA)
US8776191061 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -118.01M | -111.57M | -166.01M | -174.52M | -60.01M | |||
| Depreciation Amortization | 1.37M | 1.37M | 1.17M | 490.00K | 10.00K | |||
| Change In Working Capital | -11.51M | -16.83M | 19.83M | 28.67M | -110.00K | |||
| Interest Paid | 5.15M | 4.95M | 2.78M | 640.00K | 30.00K | |||
| Other non cash items | 55.52M | 54.01M | 56.62M | 28.32M | 29.38M | |||
| OPERATING CASH FLOW | -72.63M | -73.02M | -88.39M | -117.04M | -30.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -109.00K | -3.87M | -20.62M | -15.30M | -80.00K | |||
| Other Investing Activity | N/A | -3.48M | -4.31M | -6.25M | -9.00M | |||
| INVESTING CASH FLOW | -3.59M | -7.35M | -24.93M | -21.55M | -9.08M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -3.45M | 0.00 | 39.96M | 0.00 | |||
| Stock Issued/Repurchased | 140.83M | 140.86M | 41.86M | 0.00 | 291.06M | |||
| Other Financing Activity | -643.00K | -1.01M | 10.24M | -870.00K | N/A | |||
| FINANCING CASH FLOW | 136.74M | 136.39M | 52.10M | 39.08M | 291.06M | |||
| CHANGE IN CASH | 60.52M | 56.02M | -61.22M | -99.51M | 251.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -72.63M | -73.02M | -88.39M | -117.04M | -30.73M | |||
| Capital Expenditure | -109.00K | -3.87M | -20.62M | -15.30M | -80.00K | |||
| FREE CASH FLOW | -72.73M | -76.89M | -109.01M | -132.34M | -30.81M | |||
All data in USD